Skip to main content
CPBI
NASDAQ Finance

CPBI Shareholders Approve 10% Annual Repurchase Program; Activist-Backed Director Elected

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$20.985
Mkt Cap
$87.554M
52W Low
$14.85
52W High
$21.835
52W Position info
41% above low
Off High info
3.9% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

CPBI sits 41% above its 52-week low of $14.85.

Summary

CPBI shareholders approved a 10% annual share repurchase program and elected activist Stilwell Group's nominee Francis Younes to the board at the August 25 annual meeting.


Key Events · Corporate Governance and Compliance · CPBI

  • Share Repurchase Proposal Approved

    Stockholders approved the 10% annual share repurchase proposal with 2,320,832 votes for, 444,383 against, and 351,392 abstaining — approximately 74.5% of votes cast in favor.

  • Activist Nominee Elected to Board

    Francis E. Younes, Stilwell Group's nominee, was elected to a three-year director term with 2,908,679 votes — the highest vote total among the three directors elected.

  • Directors Re-Elected

    Steven D. Kunzman (2,831,054 votes) and Daniel D. Naranjo (2,831,354 votes) were re-elected to three-year terms.

  • Auditor Ratified

    Plante & Moran, PLLC was ratified as independent auditor for fiscal year ending March 31, 2027, with 3,534,245 votes for.


Analysis · CPBI · Finance

The annual meeting vote resolves the months-long proxy contest with activist Stilwell Group. Shareholders approved the 10% annual share repurchase proposal with 2,320,832 votes in favor (74.5% of votes cast), and Stilwell's nominee Francis Younes was elected to the board with the highest vote total among directors. The board had already committed to adopting the program in July, so this vote formalizes shareholder backing and clears the path for implementation. The repurchase program provides a mechanism to return capital to shareholders and could support the stock price, which is trading near its 52-week high.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CPBI was trading at $20.99 on NASDAQ in the Finance sector, with a market capitalization of approximately $87.6M. The 52-week trading range was $14.85 to $21.83. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CPBI - Latest Insights

CPBI
Jul 29, 2026, 4:41 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $19.85
Real-time Price: $21.48 info
Change: +$1.64 (+8%) info
Market Cap: $89.62M info
CPBI
Jul 23, 2026, 7:38 PM EDT
Filing Type: DEFC14A
Importance Score:
7
Price at Filing: $20.11
Real-time Price: $21.48 info
Change: +$1.37 (+7%) info
Market Cap: $89.62M info
CPBI
Jul 14, 2026, 5:28 PM EDT
Filing Type: DFAN14A
Importance Score:
7
Price at Filing: $19.50
Real-time Price: $21.48 info
Change: +$1.98 (+10%) info
Market Cap: $89.62M info
CPBI
Jul 09, 2026, 9:02 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $18.78
Real-time Price: $21.48 info
Change: +$2.70 (+14%) info
Market Cap: $89.62M info
CPBI
Jul 09, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.78
Real-time Price: $21.48 info
Change: +$2.70 (+14%) info
Market Cap: $89.62M info